Randomized controlled trials reflected clinical practice when comparing the course of low back pain symptoms in similar populations. by Maas ET et al.
Elsevier required licence: © <2019>. This manuscript version is made available under the CC-BY-NC-
ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/         




Randomised controlled trials reflect clinical practice when comparing the course 1 
of low back pain symptoms in similar populations 2 
Esther T Maas1,2§; Johanna M van Dongen1,2; Johan NS Juch3; J George Groeneweg3; Jan-Willem 3 
Kallewaard⁴; Michiel R de Boer1,2, Bart Koes5; Arianne P Verhagen5,6; Frank JPM Huygen3; Maurits W van 4 
Tulder1,2,7; Raymond WJG Ostelo1,2,8 5 
 6 
1. Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, The Netherlands 7 
2. Amsterdam Movement Science research institute, 1081HV Amsterdam, The Netherlands 8 
3. Department of Anaesthesiology, Erasmus Medical Centre, Rotterdam, The Netherlands 9 
4. Department of Anaesthesiology, Rijnstate hospital, Velp, The Netherlands 10 
5. Department of General Practice, Erasmus Medical Centre, Rotterdam, The Netherlands  11 
6. Graduate School of Health, Discipline of Physiotherapy, University of Technology Sydney, Ultimo, 12 
NSW 2007, Australia 13 
7. Department of Physiotherapy and Occupational Therapy, Aarhus University Hospital, Aarhus, 14 
Denmark  15 
8. Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit, The Netherlands  16 
§ Corresponding author: Esther T Maas, University of British Columbia, Faculty of Medicine, School of 17 
Population and Public health, 2206 East Mall, Vancouver, BC V6T 1Z3, Canada; E: esther.maas@ubc.ca; 18 
T: +1-604-8221228 19 
 20 
 21 




OBJECTIVE: This study compares participants in randomized controlled trials (RCTs) (the Minimal 2 
Invasive Treatment [MinT] trials) to participants in a related observational study with regard to their low 3 
back pain (LBP) symptom course.  4 
STUDY DESIGN AND SETTING: Eligible patients were diagnosed with chronic LBP originating from the 5 
facet joints (N = 615) or sacroiliac (SI) joints (N = 533) and were treated with radiofrequency denervation 6 
and an exercise program. Randomized patients were compared to patients in the related observational 7 
study who fulfilled all RCT eligibility criteria (observational group 1) and to patients who did not fulfill at 8 
least one of the RCT eligibility criteria (observational group 2). Outcomes were pain intensity, treatment 9 
success, and functional status over a 3-month period. Longitudinal mixed-model analyses and linear 10 
regression models were applied to analyze the differences in outcomes between the RCT and 11 
observational study groups.  12 
RESULTS: No differences in symptom course were found between patients in the RCTs and patients in 13 
observational group 1. Patients with facet joint pain in observational group 2 had overall less treatment 14 
success (odds ratios [OR], 0.67; 95% confidence interval [CI], 0.50-0.90), and less improvement in 15 
physical functioning (mean difference [MD], 5.82; 95% CI, 2.54-9.11) compared to the RCT patients. 16 
Patients with SI joint pain in observational group 2 had higher pain scores (MD, 0.40; 95% CI, 0.09-0.72), 17 
less treatment success (OR, 0.72; 95% CI, 0.54-0.96), and less improvement in physical functioning (MD, 18 
7.16; 95% CI, 3.84-10.47) compared to the RCT patients.  19 
CONCLUSION: This supports the generalizability of results from the MinT RCTs as this study suggests that 20 
these RCTs reflect clinical practice when comparing similar populations. To what extent this holds true 21 
for all RCTs in LBP should be further explored. 22 
 23 
  24 
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What is new? 1 
Key findings 2 
• This study suggests that the randomized controlled trial (RCT) results of the MinT trials are 3 
comparable to results of an observational study with a similar intervention and population, and only 4 
small differences are shown when the population in the observational study differs from the RCTs. 5 
 6 
What this adds to what was known? 7 
• The present study adds to the existing literature that results of pragmatic RCTs in a secondary care 8 
setting for patients who received radiofrequency denervation at the pain clinic are comparable to 9 
the results of this treatment for similar patients in daily clinical practice. 10 
 11 
What is the implication and what should change now? 12 
• Our study suggests that RCTs do reflect clinical practice when comparing similar populations and can 13 
increase the generalizability of results. Observational studies can be taken into account when 14 
assessing the symptom course after an intervention as long as the clinical features of the 15 
intervention and the included population are comparable. 16 
 17 




INTRODUCTION  2 
There is on-going debate whether results of randomised controlled trials (RCT) can be extrapolated to 3 
patients in routine care setting1–4. It has been suggested that the willingness of patients to be randomly 4 
allocated to a treatment differentiates these individuals from the average patient, and therefore 5 
participation in an RCT might influence the course of symptoms5. In addition, the strict eligibility criteria 6 
of patients participating in RCTs challenge the generalizability of RCT results6,7. Results of well-designed 7 
observational cohort studies, in turn, are presumed to resemble daily practice more closely 1–3,8,9. This 8 
raises the question to what extend the outcomes and symptom course in patients included in RCTs and 9 
observational studies are comparable. 10 
Evidence generated in observational studies is often ignored in systematic reviews as the assumption is 11 
that their findings might be biased10.One recent meta-analysis compared outcomes of RCTs and 12 
observational studies in the field of low back pain (LBP), and showed that the clinical course of LBP 13 
symptoms after a treatment in primary care followed a pattern that was similar using both study 14 
designs5. Difficulties with RCTs have been acknowledged in the assessment of surgical interventions in 15 
spinal disorders, and observational studies can be a valuable contribution to the existing knowledge11. 16 
However, it is unknown how well these comparisons between RCTs and observational studies are 17 
transferrable to a population of patients with chronic LBP in a secondary care setting.  18 
The MinT (Minimal Invasive Treatment) study was designed to evaluate the effectiveness and cost-19 
effectiveness of radiofrequency (RF) denervation added to an exercise programme for patients with 20 
chronic LBP12. RF denervation is a technique that attempts to modulate neural transmission of 21 
nociceptive stimuli, reducing spinal pain. It aims to denaturalise the nerves by applying an electric 22 
current (heat). This would prevent the conduction of nociceptive impulses13,14. RF denervation is a 23 
commonly used treatment in patients with LBP originating from the facet joints and sacro-iliac (SI) joints 24 
15,16. These sources of pain are also named as mechanical LBP16,17 and are generally assumed to be 25 
separate sources. As such, much of the literature distinguishes the entities as did we in a previous 26 
publicaiton12. 27 
The MinT study provides an excellent opportunity to compare results of RCT data with observational 28 
study data, because the study consisted of three RCTs and an observational study; and the vast majority 29 
of patients in the Netherlands who were treated with RF denervation during the inclusion period 30 
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participated in the MinT study. More details on the study design and participants can be found in the 1 
study protocol and the publication on effectiveness results12,17.  2 
The aim of this study was to assess the generalizability of the results from RCTs by comparing the course 3 
in LBP symptoms over a 3-month period in (1) randomised study groups, (2) observational study groups 4 
with patients that fulfil the eligibility criteria of the RCTs, and (3) patients in clinical practice who do not 5 
fulfil at least one of the eligibility criteria for the RCTs. This design allows us to investigate the sole 6 
impact of randomisation, as well as differences in results caused by the selection of participants in RCTs.  7 
 8 
METHODS 9 
Study design and setting 10 
The MinT study was a Dutch nationwide, multicentre study conducted in 16 pain clinics and 102 11 
physiotherapy practices12. The Medical Ethics Committee of the Erasmus University Medical Centre in 12 
Rotterdam granted ethical approval (registration number MEC-2012-079). All included patients gave 13 
written informed consent.  14 
 15 
Participants  16 
The MinT study originally consisted of four RCTs (including patients with 1) facet joint pain, 2) SI joint 17 
pain, a combination of symptoms, and 4) discogenic pain) and an observational study. One trial was 18 
designed to evaluate RF denervation for pain from the intervertebral disks. This trial was prematurely 19 
terminated because of lack of eligible patients and not included in this analysis. Tah data from the RCT 20 
for patients with a combination of symptoms was not included either because most patients in the 21 
observational study were not identified at baseline with a combination of symptoms. As such these data 22 
could not be extracted from the observational study. Patients in the facet joint trial trial were included 23 
between January 1, 2013 and June 3, 2014. Patients in the SI joint trial were included between January 24 
1, 2013 and July 1, 2014 (see Table 1). 25 
 26 
Observational study group inclusion criteria 27 
Patients were eligible for the MinT study if they had chronic (>3 months) LBP, showed no improvement 28 
of symptoms after conservative treatment, were referred to a pain clinic, and were able to complete 29 
Dutch questionnaires. For the analysis of the present study, patients in the observational groups were 30 
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included between the date of the inclusion period of the RCTs closed and December 17, 2015 (see Table 1 
1). These patients did not have the choice to be randomised, and hence resemble daily practice.  2 
 3 
RCT inclusion criteria 4 
Extra inclusion criteria for patients in the RCTs were: age between 18 and 70 years and having a positive 5 
diagnostic facet joint or SI-joint block (≥50% pain reduction 30-90 minutes after procedure). Extra 6 
exclusion criteria for the RCTs were pregnancy, anticoagulant drug therapy and/or coagulopathy, body 7 
mass index (BMI) >35, involved in a work-related conflict, and severe psychiatric or psychological 8 
problems. These eligibility criteria used in the study protocol were standardized and determined by pain 9 
physicians to ensure that the study population would be eligible for RF denervation in clinical practice in 10 
the Netherlands. 11 
More details on the eligibility criteria are reported in the study protocol12. 12 
In summary, we compared RCT patients to patients in the observational study; all with chronic LBP 13 
originating from the facet joints or SI-joints, receiving RF denervation and an exercise programme: 14 
• Randomised study group: Intervention group of the facet joint or SI-joint RCT, receiving RF 15 
denervation and physiotherapy. 16 
• Observational study group 1: Patients who fulfilled all RCT eligibility criteria, but were not 17 
randomised, and self-reported to have received RF denervation and physiotherapy. 18 
• Observational study group 2: Patients who did not fulfil at least one of the RCT eligibility criteria, 19 
were not randomised, and self-reported to have received RF-denervation and physiotherapy. 20 
These could, for example, be patients who received RF denervation but were older than 70 21 
years, or with a BMI >35. 22 
 23 
Study interventions 24 
The randomized study group received RF denervation plus a 3-month standardized exercise program 25 
combined with psychological support if necessary. RF denervation included facet joint RF denervation, 26 
or Cooled RF denervation, Simplicity III probe or Palisade technique as treatment for SI joint pain 27 
[12,19,20]. Patients were asked to refrain from any cointervention during the 3-month intervention 28 
period. Anesthesiologists at the participating pain clinics recruited the patients and carried out 29 
diagnostic blocks and RF denervation. Every participating pain clinic had a referral agreement with 30 
physiotherapy practices in their region to provide the standardized exercise program. The psychological 31 
interventions, if necessary, took place in a primary care setting. 32 
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Patients in the observational study received usual care and were monitored prospectively. For the 1 
current analysis, we selected nonrandomized patients who received facet joint or SI joint RF denervation 2 
and any form of exercise provided by a physiotherapist or exercise therapist. For patients in the 3 
observational study, this exercise program was not standardized in time or duration. 4 
 5 
Outcomes 6 
The three outcome measures were pain intensity (11-point Numerical Rating Scale [NRS]) [21], 7 
functional status (Oswestry Disability Index [ODI] 0-100) [[20], [21], [22]], and treatment success (global 8 
perceived effect [GPE], 7-point Likert scale) [23]. Treatment success measured by the GPE scale was 9 
defined as patients reporting to be “much improved” or “completely recovered.” 10 
Minimal clinically important change scores for patients with chronic LBP were estimated at 30% on the 11 
NRS for pain and 8 to 12 points on the ODI for functional status to be clinically relevant [24,25]. 12 
Age, gender, BMI, education, smoking habits, marital status, complaint history, and patient expectations 13 
were assessed on baseline. Patient expectations were assessed by the Credibility/Expectancy 14 
Questionnaire [26]. Health care utilization in primary and secondary care and the use of prescribed and 15 
over-the-counter medication were assessed by self-completed cost questionnaires [27]. 16 
All patients in the RCTs as well as observational study received the same questionnaires and were 17 
followed up for 12 months. For this study, we used the results up to the first 3 months of follow up, as 18 
we expected a randomization effect mostly during this 3-month intervention period. All questionnaires 19 
were web-based and sent at baseline and 3 months after start of treatment. Pain intensity and GPE 20 
were assessed at three and 6 weeks after start of treatment as well. 21 
 22 
Statistical methods 23 
Baseline characteristics of patients in the RCT intervention group and in the observational study were 24 
compared using descriptive statistics. We compared the randomized study groups pairwise to each of 25 
the two observational study groups, separately for LBP originating from the facet joints and SI joints. 26 
Baseline characteristics were compared between completers and noncompleters to identify possible 27 
selective dropout. 28 
The analysis of mean changes for pain intensity included all available data for each of the predetermined 29 
follow-up assessments at 3 weeks, 6 weeks, and 3 months. To analyze differences between the groups in 30 
pain intensity, we used a maximum likelihood estimation from longitudinal linear mixed-effects models 31 
under “missing at random” assumptions, and included a fixed term for pain clinic if necessary, based on 32 
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the likelihood ratio test [28]. This fixed term for pain clinic was added to the model only for analyzing 1 
patients with facet joint pain. 2 
For treatment success (dichotomous outcome), we used a generalized linear mixed model (logit link) 3 
with the same multilevel structure under “missing at random” assumptions and also included a fixed 4 
term for pain clinic if necessary, based on the likelihood ratio test [28]. This fixed term for pain clinic was 5 
added to the model for analyzing both patients with facet joint pain and SI joint pain. 6 
Functional status was assessed at 3 months only. Analyzing differences in functional status was 7 
performed using a linear regression model. 8 
For all analyses, we calculated regression coefficients or odds ratios with 95% confidence intervals and 9 
performed an unadjusted analysis and an analysis adjusted for baseline outcomes. We included 10 
time*group interactions in all models, and time-specific associations are presented, regardless of the 11 
statistical significance of these interaction terms. We used MLwiN to analyze the data (V2.22). 12 
We preplanned a complete-case analysis as sensitivity analysis, including complete cases from the RCT 13 
(Facet RCT N = 98; SI joint RCT N = 87) and complete cases from the 3- and 6-week measurements in the 14 
observational groups (facet joint observational study group 1, N = 268; facet joint observational study 15 
group 2. N = 295; SI joint observational study group 1, N = 187; SI joint observational study group 2, N = 16 
235). In the observational study groups, we selected patients based on self-reported RF denervation and 17 
physiotherapy. Self-reported treatments were assessed at the end of the 3-month online questionnaire. 18 
In this questionnaire, the outcomes were measured before the treatments and because participants 19 
were instructed to answer each question to continue the questionnaire, there were no missing data in 20 
any of the outcomes for the observational groups at 3 months. 21 
 22 
RESULTS 23 
In total, 7,529 patients were included in one of the RCTs or the observational group in the MinT study 24 
between January 1, 2013 and December 17, 2015. Most patients were excluded from the RCTs because 25 
of psychological problems (i.e., depressive symptoms or anxiety) or because they were older than 26 
70 years; for a complete overview of exclusions, see Appendix A. 27 
In total, 1,148 patients fulfilled the eligibility criteria for the present study (see Figure 1). Of the patients 28 
with LBP originating from the facet joints, 125 patients were randomized to the intervention group, 257 29 
patients participated in observational group 1 (fulfilling all of the RCT eligibility criteria), and 233 30 
patients participated in observational group 2 (not fulfilling the RCT eligibility criteria). Of the patients 31 
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with LBP originating from the SI joints, 116 patients were randomized to the intervention group, 198 1 
patients in observational group 1, and 219 in observational study group 2. 2 
 3 
Patient characteristics 4 
Baseline characteristics are shown in Table 2. The total study population had a mean age of 55.6 years 5 
(SD 13.4), the majority was women, had a low education level, married, and had on average 13 years (SD 6 
12.5) of LBP symptoms. During the 3-month follow-up, most of the patients visited primary care more 7 
than 10 times, visited the outpatient clinic at least once, and were never hospitalized (Table 3). On 8 
average, 20% of the patients used weak opioids and 4–18% used strong opioids (Table 3). 9 
Patients in observational study group 2 were somewhat older, had a lower education level, less likely to 10 
have a paid job, had slightly more functional limitations at baseline, and more often used strong opioids 11 
compared with randomized patients and patients in observational study group 1 12 
(Table 2, Table 3, Table 4). This applied to patients with chronic LBP originating from the facet joints and 13 
the SI joints. 14 
There were hardly any differences between completers and noncompleters in baseline characteristics, 15 
health care use, medication, and outcomes (Appendix B and Appendix C). The number of complete cases 16 
ranged from 77% to 89% between the groups (Figure 1). 17 
 18 
Comparison between randomised patients and patients in the observational study 19 
Facet joints 20 
The mean pain intensity for patients with LBP originating from the facet joints in the first 3 weeks after 21 
RF denervation decreased by 1.97 points (on an 11-point scale) in the randomized study group, 2.07 22 
points in observational group 1, and 1.76 in observational group 2. Pain intensity stabilized afterward 23 
(Table 4 and Figure 2). 24 
 25 
Comparing observational group 2 with the RCT 26 
No statistical significantly or clinically relevant differences in improvement in pain intensity between 27 
patients in observational study group 2 and randomized patients were found. Statistically significantly 28 
less improvement in functional status in patients was shown in observational study group 2 compared 29 
with randomized patients (mean difference [MD] 5.82; 95% CI: 2.54–9.11) on a 0–100 scale. However, 30 
this difference is not considered clinically relevant (i.e., < 8 to 12 points on the ODI). We found a smaller 31 
10 
 
treatment success in observational study group 2 compared with the RCT overall and at each time point 1 
(three and 6 weeks, and 3 months after intervention) (Table 4). 2 
 3 
SI-joints 4 
The mean pain intensity for patients with LBP originating from the SI joints decreased 2.21 points in 5 
randomized patients in the first 3 weeks after receiving RF denervation, 2.31 points in observational 6 
group 1, and 2.05 points in observational group 2. This stabilized afterward (Table 4 and Figure 2).\ 7 
 8 
Comparing observational group 1 with the RCT 9 
We found no differences in course of LBP symptoms based on pain, functional status, and treatment 10 
success between patients in observational study group 1 and randomized patients. 11 
 12 
Comparing observational group 2 with the RCT 13 
Participants in observational study group 2 had statistically significant less pain reduction overall (MD, 14 
0.40; 95% CI: 0.09–0.72) on a 0–10 scale, and at the 3-month assessment as well (MD, 0.58; 95% CI 15 
0.05–1.11). However, these MDs are small and not considered clinically relevant (i.e., < 30% on the NRS 16 
for pain intensity). Participants in observational study group 2 also had less improvement in functional 17 
status (MD, 7.16; 95% CI: 3.84–10.47) on a 0–100 scale over the 3-month period and overall less 18 
treatment success (OR, 0.72; CI: 0.54–0.96) compared with randomized patients. These differences are 19 
not considered clinically relevant either. 20 
 21 
Sensitivity analysis  22 
The percentage of patients with LBP originating from the facet joints who had complete data on all 23 
measurement points was almost 10% higher in the observational study compared with the randomized 24 
study groups (78.4% in the RCT vs. 88.3% in observational study group 1 and 89.0% in observational 25 
study group 1, respectively). Among patients with chronic LBP originating from the SI joints, the 26 
percentage of complete cases was 75.0% in the randomized study group and 76.8% and 77.6% in both 27 
study groups, respectively (see Figure 1). 28 
We found merely negligible differences between the main analysis and complete case analysis 29 
(Appendix D). 30 
Models without adjustments for baseline outcome differences (Appendix E) showed similar results in 31 
pain intensity and showed larger MDs between the observational study groups and the randomized 32 
11 
 
study groups in ODI scores. One explanation for this could be regression to the mean because the 1 
observational study groups started out with a higher pain intensity score and more limitations in 2 
functional status. 3 
 4 
DISCUSSION  5 
Main results 6 
This study compared the symptom course between randomized study groups and observational study 7 
groups for patients with chronic LBP originating from the facet joints or SI joints who were treated with 8 
RF denervation and an exercise program. Our results suggest that these patients experience similar 9 
levels of pain and functioning and improvement whether randomized to a treatment group or 10 
undergoing treatment in an observational study as long as all patients fulfill eligibility criteria. When this 11 
is not the case (i.e., patients did not fulfill all the inclusion criteria), small but seemingly clinically 12 
irrelevant differences were observed; patients from observational studies show higher pain intensity 13 
score, more limitations in functional status, and less treatment success compared with randomized 14 
patients. Descriptive statistics showed that patients who did not fulfill all RCT inclusion criteria were 15 
somewhat older, had a lower education level, were less likely to have a paid job, had slightly more 16 
functional limitations at baseline, and more often used strong opioids compared with randomized 17 
patients and patients who did meet all RCT inclusion criteria. These patients were more likely to have a 18 
slightly worse symptom course, which might imply that the results of the RCT are a minor 19 
overestimation of the results in real life (which we consider a real-life combination of patients in 20 
observational groups 1 and 2). 21 
Previous studies estimated minimal change scores for patients with LBP of 30% on the NRS for pain, and 22 
8 to 12 points on the ODI for functional status to be clinically relevant [24,25]. All study groups in our 23 
study showed average changes less than 30% on the NRS for pain intensity and less than 10 points in 24 
functional status over time on the ODI. The differences between the randomized and observational 25 
study groups in the present study cannot be considered clinically relevant. 26 
All in all, this study suggests that (1) the RCT results of the MinT trials reflect clinical practice in a similar 27 
population and (2) participants in the RCT show slightly better results compared with the observational 28 
group in clinical practice that does not meet all eligibility criteria. This study adds to the current 29 
literature that results of pragmatic RCTs (more specifically, the clinical course of patients in the 30 
intervention arm) in a secondary care setting for patients who received RF denervation at the pain clinic 31 




Strengths and limitations 2 
A strength of the present study is the nationwide study design, which resulted in a large sample of 3 
patients who were recruited in routine clinical care. Second, patients who were randomly allocated to 4 
be treated with RF denervation and an exercise program could be compared with patients who received 5 
a similar treatment but had a treatment choice in the observational study groups. This increased the 6 
applicability of the results in clinical practice, which is probably the average of the outcomes in 7 
observational groups 1 and 2. In other words, it shows that the symptom course is probably not affected 8 
by randomization. This supports the generalizability of the RCT results. 9 
A limitation of this study was the inability to select a proper control group that was more or less 10 
comparable to the control group in the RCT, using the observational data. The variety of physiotherapy 11 
treatments would have made it impossible to select a group of patients with a comparable treatment as 12 
the standardized exercise program in the RCT control group. Therefore, it was not possible to perform a 13 
nonrandomized comparison of RF denervation in addition to an exercise program vs. an exercise 14 
program alone. Various studies and one meta-analysis performed a nonrandomized treatment 15 
comparison in the field of LBP [[29], [30], [31], [32]]. These studies showed similar results in clinical 16 
course of LBP symptoms compared with the present study. However, these previous studies analyzed a 17 
variety of mostly conservative treatments, and clinical heterogeneity could potentially have influenced 18 
the results. 19 
Second, a reference standard for diagnosing facet joint or SI joint pain is not available [14]. In this 20 
pragmatic study, diagnostic tests that are commonly applied in clinical practice were used. Controversy 21 
concerning the ideal threshold value of pain reduction in the diagnostic blocks exists. A 50% cutoff has 22 
most frequently been used in previous studies [14] and in clinical practice. Performing two or more 23 
independent diagnostic blocks decreases the false-positive rate but increases the number of false-24 
negative blocks [33]. Furthermore, a clinical trial showed that multiple blocks are not cost-effective [31]. 25 
Third, other patients may present themselves at the pain clinic in daily practice compared with the 26 
patients we included in the present study. However, the inclusion criteria of the RCTs are in line with 27 
treatment criteria in daily practice, and more importantly, the vast majority of patients in the 28 
Netherlands who were treated with RF denervation during the inclusion period participated in the MinT 29 
study. This was the result of a governmental regulation that only patients who participated in the MinT 30 
study were reimbursed for the treatment costs by their health insurance company. For that reason, we 31 
expect that patients in this study reflect patients in clinical practice more closely. 32 
13 
 
Fourth, the relatively large attrition is a potential limitation. However, most of the attrition is explained 1 
by the selection of patients with diagnosed SI and facet joint pain who were included in the 2 
observational study after the RCT inclusion period was closed. However, there was a relatively large 3 
number of dropouts at 12 months. Although we did not define differences between the complete-case 4 
analysis and the intention-to-treat analysis using all data, it is possible that completers are different 5 
from noncompleters, which could have biased the results of the complete-case analyses. 6 
 7 
Reflections 8 
Systematic reviews in health care often ignore the evidence generated in observational studies, as the 9 
general assumption is that observational studies overestimate the effects of treatments tested in RCTs 10 
[2,34]. Moreover, observational findings are more likely to be biased and are based on studies that lack 11 
a comparable control group. The difference in results between RCTs and observational studies are 12 
usually attributed to differences in methodological quality. A recent meta-analysis provides evidence to 13 
the contrary [35]. This meta-analysis examined factors that explain heterogeneity in clinical outcomes in 14 
the field of LBP, of which study design is one of the factors. The authors concluded that other effect 15 
modifiers were frequently more powerful explanatory variables than study design. These factors 16 
included pain duration, involvement of workers’ compensation, presence of spondylolisthesis, levels 17 
fused, and previous surgery [35]. The results of the meta-analysis are in line with our results and suggest 18 
that differences between RCTs and observational study results in the field of LBP are primarily 19 
attributable to clinical factors and not by the difference in study design. More data have become 20 
available that show similar clinical course results from observational studies and RCTs in fields outside 21 
[2,[36], [37], [38]], as well as inside the field of LBP [5,35]. The results of our study seem to support 22 
these findings. 23 
We acknowledge differences in techniques between countries and settings. Needle size and placement, 24 
duration, and temperature of RF denervation could be some of these differences. We encourage 25 
researchers and clinicians in other countries or settings to evaluate whether these procedures reflect 26 
their daily practice. Second, researchers can consider matching (e.g., by propensity score matching or 27 
coarsened exact matching) on demographic characteristics of patients in observational studies and 28 
patients in RCTs to further investigate randomization bias. 29 
Most LBP studies show small treatment effects and the clinical course in symptoms tend to improve in 30 
the first 6 weeks, reaching a plateau over the following 12 months [39,40]. Our study results are in line 31 
with these findings in previous literature. It seems more likely that differences between study results 32 
14 
 
can be attributed to study setting, population, intervention, or other discrepancies between studies and 1 
not to study design itself [41]. We encourage future research using data from routine clinical care (real-2 
life data). This might be promising for evaluating effectiveness of clinical interventions in situations 3 
when performing an RCT is complex or unethical, but methodological challenges need to be addressed, 4 
such as, for example, confounding by indication. 5 
 6 
Conclusion 7 
Despite the belief that observational studies are assumed to overestimate the effects of interventions 8 
evaluated in RCTs, our study showed fairly similar outcomes in pain, functioning, and treatment success 9 
after RF denervation over a 3-month time in patients with chronic LBP originating from the facet joints 10 
and SI joints in a randomized study treatment population compared with similar patients from an 11 
observational study. 12 
 13 
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FIGURE 1. FLOW CHART
Excluded: N=6381 
• Included in SI-joint RCT: control group: n= 112 
• Included in Combination RCT: n= 202 
• Included in facet joint RCT: control group: n=126 
• Not treated with RF denervation: n=3245 
• Treated with RF denervation, but no exercise: n=2024 
• Inclusion criteria unknown: n=385 
• No isolated SIJ or facet joint pain: n=14 
• In observational study during RCT period: N=273 






Complete cases  








Complete cases  
N= 227 (88.3%) 
 





Complete cases  
N= 208 (89.0%) 
 





Complete cases  






Complete cases  
N= 152 (76.7%) 
 





Complete cases  
N= 170 (77.6%) 
 
Observational group 2 
N=219 Follow-up 
CLBP originating from the facet joints, receiving RF 
denervation and an exercise programme (n=615) 
CLBP originating from the SI-joints, receiving RF 
denervation and an exercise programme (n=533) Allocation 
Patients in observational study eligible for the current study: n=907 
Patient in the intervention group of the facet joint RCT: n=125 
Patient in the intervention group of the SI-joint RCT: n=116 
 
Total included patient: N=1148 
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TABLE 1. DESCRIPTIVE BASELINE CHARACTERISTICS – CLBP ORIGINATING FROM THE FACET 
JOINTS AND THE SI-JOINTS 
Abbreviations: SD, Standard Deviation; No, number; BMI, Body Mass Index (calculated as weight in kilograms 
divided by height in meters squared); IQR: Inter Quartile Range; SD: Standard Deviation; CEQ, credibility 
expectancy questionnaire 
A Results are presented of the patients who had complete baseline data 
B Education levels: Low indicated preschool, primary school or lower secondary school; moderate indicates higher 
secondary school or undergraduate; high indicates tertiary, university, or postgraduate. 
C A higher score indicates more credibility in the effectiveness of treatment or higher expectations about the 






 Patients with CLBP originating from the facet jointsA Patients with CLBP originating from the SI-jointsA 



















Age, mean (SD), y 52.9 (11.5) 53.3 (11.04) 62.7 (13.91) 51.6 (10.9) 51.4 (11.0) 57.4 (15.6) 
Women, No. (%) 65 (55.6%) 163 (63.4%) 144 (61.8%) 87 (75.0%) 150 (79.8%) 165 (78.2%) 
BMI, mean (SD) 26.7 (5.2) 27.1 (3.8) 29.0 (5.8) 26.7 (4.2) 26.5 (3.8) 28.9 (6.3) 
Smoker, No. (%) 34 (29.1%) 67 (26.1%) 51 (21.9%) 29 (26.6%) 42 (22.3%) 50 (23.7%) 
Education level, No, 
(%)B 
       
• Low  57 (48.7%) 116 (45.1%) 136 (58.4%) 59 (54.1%) 80 (42.6%) 119 (56.9%) 
• Moderate  35 (29.9%) 80 (31.1%) 50 (21.5%) 32 (29.4%) 74 (39.4%) 62 (29.7%) 
• High  21 (17.9%) 61 (23.7%) 47 (20.2%) 18 (16.5%) 34 (18.1%) 28 (13.4%) 
History of back pain 
complaints, median  
(IQR), months 
       
• Time since first 
experience with 
low back pain  
146 (50-267) 122 (37-244) 137 (50-266) 97 (37 -228) 122(37 – 241) 164 (37 – 244) 
• Time since first 
current episode 
with low back 
pain   
31 (12-103) 30 (12-67) 48 (13-122) 30 (12 – 76) 30 (12 – 85) 30 (12 – 73) 
Married, or living with 
a partner, No. (%) 
93 (74.4%) 215 (83.7%) 166 (71.2%) 85 (78.0%) 143 (76.1%) 143 (68.1%) 
CEQ score, mean (SD)C       
• Credibility (0-27) 21.4 (3.9) 21.4 (4.2) 21.4 (3.9) 21.4 (4.5) 22.6 (3.2) 21.4 (4.0) 
• Expectancy (0-27) 18.9 (4.6) 18.7 (4.7) 18.1 (4.6) 18.8 (4.9) 19.5 (4.3) 18.2 (4.8) 
Having a paid job (%) 64 (51.2%) 144 (56.3%) 47 (20.2%) 66 (61.7%) 107 (54.0%) 70 (32.6%) 
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Table 2. Descriptive healthcare and medication use – LBP originating from the facet joints and 
the SI-joints 
Abbreviations: NSAIDS: Nonsteroidal anti-inflammatory drugs 
 Patients with CLBP originating from the  
facet joints 
Patients with CLBP originating from the  
SI-joints 



















Primary care visits       
• 0 (%) 12 (10.1%) 0 (0.0%) 0 (0.0%) 0 (0%) 0 (0.0%) 0 (0.0%) 
• <10 (%) 27 (22.7%) 108 (42.0%) 94 (40.3%) 32 (29.4%) 95 (48.0%) 98 (44.7%) 
• ≥10 (%) 80 (67.2%) 149 (58.0%) 139 (59.7%) 77 (70.6%) 103 (52.0%) 121 (55.3%) 
Outpatient clinic        
• 0 (%) 49 (41.2%) 79 (30.7%) 71 (30.5%) 43 (39.4%) 73 (36.9%) 70 (32.0%) 
• ≥1 (%) 70 (58.8%) 178 (69.3%) 162 (62.5%) 66 (56.9%) 125 (63.1%) 149 (68.0%) 
One day treatment       
• 0 (%) 77 (64.7%) 141 (54.9%) 145 (62.2%) 62 (56.9%) 117 (59.1%) 132 (60.3%) 
• ≥1 (%) 42 (35.3%) 116 (45.1%) 88 (37.8%) 47 (43.1%) 81 (40.9%) 87 (39.7%) 
Hospitalisation       
• 0 (%) 119 (100.0%) 252 (98.1%) 230 (98.7%) 108 (99.1%) 193 (97.5%) 218 (99.5%) 
• ≥1 (%) 0 (0.0%) 5 (1.9%) 3 (1.3%) 1 (0.9%) 5 (2.5%) 1 (0.5%) 
Medication use        
• None/non back pain 
related 
46 (39.7%) 77 (30.0%) 59 (25.3%) 37 (34.3%) 54 (27.3%) 60 (27.4%) 
• Non-opioids (%) 
(aspirin/paracetamol/NSAIDs) 
42 (36.2%) 104 (40.5%) 77 (33.0%) 53 (38.9%) 81 (40.9%) 78 (35.6%) 
• Weak opioids (%) 
(with or without non-opioids) 
23 (19.8%) 46 (17.9%) 54 (23.2%) 24 (22.2%) 41 (20.7%) 48 (21.9%) 
• Strong opioids (%) 
(with or without non-opioids) 
5 (4.3%) 28 (10.9%) 41 (17.6%) 5 (4.6%) 21 (10.6%) 29 (13.2%) 
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 Table 3. Outcomes of the observational study groups compared to the randomised study groups 
Values presented are means with corresponding standard deviations (SD), percentages of recovered patients, and model estimates of linear mixed-effects models with a random intercept, adjusted 
for pain intensity and functional status at baseline. Regression coefficients can be interpreted as mean differences between both observational groups compared to the RCT at a certain follow-up 
moment compared to baseline. Abbreviations: OR. Odds Ratio; NRS. Numeric Rating Scale (0-10); GPE. Global Perceived Effect; ODI. Oswestry Disability Index (0-100). 
Higher score indicates more severe symptoms. 
  
Patients with CLBP originating from the facet joints Patients with CLBP originating from the SI-joints 










































 Baseline 7.14 (1.38) 7.11 (1.395)  7.55 (1.38)  7.17 (1.65) 7.56 (1.33)  7.46 (1.44)   
3 weeks  5.17 (2.27) 5.04 (2.156) -0.28 
(-0.76-0.21) 
5.79 (2.09) 0.29 
(-0.20-0.79) 
4.96 (2.19) 5.25 (2.20) 0.13 
(-0.45-0.72) 
5.41 (2.34) 0.38 
(-0.19-0.95)  
6 weeks 5.19 (2.31) 5.02 (2.25) -0.22 
(-0.69-0.25) 
5.66 (1.99) 0.26 
(-0.22-0.74) 
5.22 (2.16) 4.89 (2.23) -0.45 
(-0.99-0.09) 
5.60 (2.26) 0.25 
(-0.28-0.78)  
3 months 5.01 (2.29) 5.00 (2.350) -0.04 
(-0.50-0.43) 
5.68 (2.13) 0.40 
(-0.11-0.92) 
4.77 (2.46) 5.17 (2.38) 0.27 
(-0.27-0.80) 
5.45 (2.27) 0.58 
(0.05-1.11)* 




Baseline  35.08  (14.66) 28.24 (14.05)  46.07 (14.89)  38.07 (14.07) 41.01 (13.39)  46.22 (13.73)  
 3 months 26.03 (16.58) 30.53 (16.57) 1.47 
(-1.67-4.60) 
40.21 (17.55) 5.82 
(2.54-9.11) 
27.72 (17.05) 31.33 (15.01) 1.98 
(-1.33-5.29) 
39.94 (16.95) 7.16 
(3.84-10.47) 
            





  0.99 
(0.75-1.3) 
 0.67  
(0.50-0.90) 




 3 weeks  32 (29.6%) 63 (27.5%) 0.90 
(0.54-1.49) 
45 (21.1%) 0.64 
(0.38-1.08) 
28 (29.8%) 47 (29.7%) 0.98 
(0.56-1.72) 
47 (26.4%) 0.83 
(0.48-1.45) 
 6 weeks 35 (29.4%) 81 (32.1%) 1.14 
(0.71-1.83) 
60 (26.7%) 0.87 
(0.53-1.43) 
40 (37.0%) 63 (33.2%) 0.84 
(0.51-1.38) 
61 (28.5%) 0.68 
(0.42-1.11) 
 3 months 43 (36.1%) 89 (34.6%) 0.94 
(0.59-1.48) 
55 (23.6%) 0.55 
(0.34-0.88) 
43 (39.1%) 77 (38.9%) 0.98 
(0.61-1.57) 




Figure 2. Course in low back pain symptoms at baseline until three months follow-up 
 










2. Patients with chronic LBP originating from the SI-joints 
Values presented are unadjusted mean outcome score at baseline and each follow-up moment. Abbreviation: NRS. Numeric Rating Scale (0-10); GPE. Global Perceived Effect; ODI. Oswestry Disability 






APPENDIX 1 REASONS FOR EXCLUSION FROM THE RCT 
Exclusion criteria Patients with CLBP 




Patients with CLBP originating 




Psychological problems  88 (37.8%) 108 (49.3%) 
Age >70  58 (24.9%) 32 (14.6%) 
Psychological problems & age>70  24 (10.3%) 17 (7.8%) 
BMI>35  21 (9.0%) 22 (10.0%) 
Negative diagnostic block  16 (6.9%) 20 (9.1%) 
Psychological problems & BMI>35  11 (4.7%) 8 (3.7%) 
Psychological problems & negative diagnostic block  5 (2.1%) 7 (3.2%) 
Negative diagnostic block & age>70  3 (1.3%) 0 (0.0%) 
Age>70 & BMI>35  2 (0.9%) 1 (0.5%) 
Psychological problems & age>70 & BMI>35  1 (0.4%) 2 (0.9%) 
Negative diagnostic block & BMI>35  2 (0.9%) 0 (0.0%) 
Psychological problems & BMI>35 & negative diagnostic block  2 (0.9%) 1 (0.5%) 
Psychological problems & age>70 & negative diagnostic block  0 (0.0%) 1 (0.5%) 







Appendix 2. Complete case descriptive baseline characteristics – CLBP originating from the 
facet joints and the SI-joints 
Abbreviations: SD, Standard Deviation; No, number; BMI, Body Mass Index (calculated as weight in kilograms 
divided by height in meters squared); IQR: Inter Quartile Range; SD: Standard Deviation; CEQ, credibility 
expectancy questionnaire 
A Results are presented of the patients who had complete data 
B Education levels: Low indicated preschool, primary school or lower secondary school; moderate indicates higher 
secondary school or undergraduate; high indicates tertiary, university, or postgraduate. 
C A higher score indicates more credibility in the effectiveness of treatment or higher expectations about the 
treatment (score range, 0-27) 
 
 
 Patients with CLBP originating from the 
facet jointsA 
Patients with CLBP originating from the  
SI-jointsA 



















Age in years (SD) 53.6 (11.3) 53.6 (11.1) 62.7 (13.8) 51.9 (10.9) 50.9 (11.1) 57.4 (15.3) 
Female  54 (55.1%) 143 (63.0%) 127 (61.1%) 70 (80.5%) 124 (81.6%) 129 (75.9%) 
BMI (SD) 26.6 (5.2) 27.2 (3.8) 29.0 (5.7) 26.5 (4.2) 26.3 (3.8) 29.0 (6.5) 
Smoker  29 (29.6%) 59 (26.0%) 47 (22.6%) 25 (28.7%) 34 (22.4%) 43 (25.3%) 
Education B       
• Low 48 (49.0%) 106 (46.7%) 124 (59.6%) 49 (56.3%) 66 (42.8%) 96 (56.5%) 
• Moderate  29 (29.6%) 69 (30.4%) 44 (21.2%) 25 (28.7%) 60 (39.5%) 49 (28.8%) 
• High  21 (21.4%) 52 (22.9%) 40 (19.2%) 13 (14.9%) 26 (17.1%) 24 (14.1%) 
History of back pain complaints         
• Months  first LBP 
experience (median (IQR)) 
146 (52-271) 122 (37-243) 194 (52-291) 120 (37-231) 115 (37-115) 97 (37-282) 
• Months with current LBP 
episode (median (IQR))   
30 (12-97) 28 (12-67) 49 (14-123) 30 (10-79) 28 (12-85) 33 (12-73) 
Married  77 (78.6%) 189 (83.3%) 146 (70.2%) 70 (80.5%) 117 (77.0%) 119 (69.4%) 
Expectations C       
• Credibility (0-27) 21.5 (2.59) 21.4 (4.2) 21.4 (4.0) 21.1 (4.5) 22.9 (3.2) 21.4 (3.9) 
• Expectancy (0-27) 19.2 (4.4) 18.6 (4.8) 18.2 (4.6) 18.5 (4.9) 19.6 (4.4) 18.3 (4.7) 
Having a paid job  52 (53.6%) 130 (57.3%) 41 (19.7%) 51 (60.0%) 87 (57.2%) 58 (34.1%) 
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APPENDIX 3. COMPLETE CASE DESCRIPTIVE HEALTHCARE AND MEDICATION USE – CLBP 
ORIGINATING FROM THE FACET JOINTS AND THE SI-JOINTS 
 
 
 Patients with CLBP originating from the  
facet joints 
Patients with CLBP originating from the SI-
joints 



















Primary care visits       
• 0  9 (9.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
• <10  20 (20.4%) 94 (41.1%) 83(39.9%) 25 (28.7%) 71 (46.7%) 75 (44.1%) 
• ≥10  69 (70.4%) 133 (58.6%) 125 (60.1%) 62 (71.3%) 81 (53.3%) 95 (55.9%) 
Outpatient clinic        
• 0  40 (40.8%) 72 (31.7%) 62 (29.8%) 35 (40.2%) 54 (35.5%) 55 (32.4%) 
• ≥1  58 (59.2%) 155 (68.3%) 146 (70.2%) 52 (59.8%) 98 (64.5%) 115 (67.6%) 
One day treatment       
• 0  65 (66.3%) 120 (52.9%) 128 (61.5%) 47 (54.0%) 88 (57.9%) 104 (61.2%) 
• ≥1  33 (33.7%) 107 (47.1%) 80 (38.5%) 40 (46.0%) 64 (42.1%) 66 (38.8%) 
Hospitalisation       
• 0  98 (100%) 223 (98.2%) 205 (98.6%) 86 (98.9%) 149 (98.0%) 169 (99.4%) 
• ≥1  0 (0.0%) 4 (1.8%) 3 (1.4%) 1 (1.1%) 3 (2.0%) 1 (0.6%) 
Medication use        
• None/non back pain 
related 
36 (36.7%) 68 (30.0%) 53 (25.5%) 32 (37.2%) 45 (29.6%) 46 (27.1%) 
• Non-opioids 
(aspirin/paracetamol/NSAID) 
38 (39.2%) 91 (40.1%) 66 (31.7%) 31 (36.0%0 60 (39.5%) 67 (39.4%) 
• Weak opioids  
(with or without non-opioids) 
19 (19.6%) 40 (17.6%) 49 (23.6%) 19 (21.8%) 28 (18.4%) 36 (21.2%) 
• Strong opioids  
(with or without non-opioids) 
4 (4.1%) 26 (11.5%) 38 (18.3%) 4 (4.7%) 18 (11.8%) 19 (11.2%) 
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APPENDIX 4. COMPLETE CASE ANALYSIS: TREATMENT EFFECTS OF OBSERVATIONAL STUDY GROUPS COMPARED TO THE RCT 
Values presented are model estimates of linear mixed-effects models with a random intercept, and adjusted for outcomes at baseline. Regression coefficients can be interpreted as mean differences 
between interventions at a certain follow-up moment compared to baseline. Abbreviation: OR. Odds Ratio; NRS. Numeric Rating Scale (0-10); GPE. Global Perceived Effect; ODI. Oswestry Disability 
Index (0-100). Higher score indicates more severe symptoms.  
  
Patients with CLBP originating from the facet joints Patients with CLBP originating from the SI-joints 


























NRS Pain  
(SD) 




  0.01  
(-0.49-0.51) 
 0.34  
(-0.14-0.83) 
 Baseline 7.10 (1.41) 7.12 (1.35)  7.52 (1.41)  7.03 (1.76) 7.67 (1.17)  7.41 (1.43)   
3 weeks  5.20 (2.22) 5.05 (2.16) -0.16  
(-0.66-0.34) 
5.76 (2.09) 0.40  
(-0.11-0.91) 
5.01 (2.21) 5.22 (2.23) 0.08  
(-0.52-0.69) 
5.43 (2.35) 0.35 
(-0.24-0.93)  
6 weeks 5.12 (2.33) 5.04 (2.56) -0.09 
(-0.60-0.41) 
5.66 (1.96) 0.38 
(-0.13-0.91) 
5.21 (2.17) 4.99 (2.19) -0.34 
(-0.94-0.27) 
5.51 (2.33) 0.23 
(-0.36-0.82)  
3 months 4.87 (2.25) 5.03 (2.36) 0.16 
(-0.35-0.66) 
5.72 (2.13) 0.70 
(0.19-1.21) 
4.74 (2.54) 5.14 (2.39) 0.29 
(-0.32-0.89) 
5.26 (2.29) 0.45 
(-0.14-1.04) 
            
ODI Functioning (SD) Baseline  35.33 (14.49) 38.28 (13.88)  46.18 (15.02)  38.51 (14.05) 40.71 (13.33)  45.32 (13.84)  
 3 months 26.22 (17.12) 30.78 (16.71) 2.39 
(-0.88-5.56) 
40.25 (17.68) 6.26 
(2.84-9.68) 
27.10 (17.51) 30.15 (14.44) 1.61 
(-2.03-5.25) 
 
38.04 (16.98) 6.72 
(3.10-10.35) 
            
    OR  (95%CI)  OR  (95%CI)   OR  (95%CI)  OR  (95%CI) 








 3 weeks  30 (30.6%) 62 (27.3%) 0.85 
(0.47-1.55) 
45 (21.6%) 0.63 
(0.34-1.16) 
26 (29.9%) 47 (30.9%) 0.05 
(-0.61-0.71) 
45 (26.5%) -0.17 
(-0.83-0.49) 
 6 weeks 29 (29.6%) 74 (32.6%) 1.15 
(0.63-2.09) 
54 (26.0%) 0.83 
(0.45-1.54) 
34 (39.1%) 49 (32.2%) -0.30 
(-0.94-0.34) 
52 (30.6%) -0.38 
(-1.01-0.26) 
 3 months 37 (37.8%) 79 (34.8%) 0.88 
(0.49-1.57) 
47 (22.6%) 0.48 
(0.26-0.88) 
35 (40.2%) 60 (39.5%) -0.03 
(-0.66-0.60) 
57 (33.5%) 0.29 
(-0.34-0.91) 
